CORSINI, ALBERTO
CORSINI, ALBERTO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
2024 consensus document of the Italian Society of Arterial Hypertension (SIIA) and the Italian Society of Cardiovascular Prevention (SIPREC): update on LDL cholesterol lowering in patients with arterial hypertension
2025 M.L. Muiesan, A. Virdis, G. Tocci, C. Borghi, A.F.G. Cicero, C. Ferri, M. Pirro, A. Corsini, M. Volpe
Impact of cigarette smoke on vascular smooth muscle cell senescence
2024 C. Rossi, M. Venturin, C. Battaglia, A. Corsini, S. Bellosta
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
2024 S. Bellosta, A. Corsini
Vescicole extracellulari nel contesto dell'aterosclerosi = Extracellular vesicles in atherothrombosis
2024 M. Ruscica, A. Rizzuto, C. Macchi, I. Fichtner, S. Carugo, A. Corsini
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
2024 N. Ferri, M. Ruscica, S. Fazio, A. Corsini
Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action?
2024 I. Fichtner, C. Macchi, A.S. Rizzuto, S. Carugo, A. Corsini, M. Ruscica
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
2024 L. Barbieri, G. Tumminello, I. Fichtner, A. Corsini, R.D. Santos, S. Carugo, M. Ruscica
Lipid-lowering approaches to manage statin-intolerant patients
2024 M. Ruscica, A. Bertoletti, C. Gobbi, C.R. Sirtori, S. Carugo, A. Corsini
Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity
2024 C. Macchi, A. Giachi, I. Fichtner, S. Pedretti, P.S. Puttini, N. Mitro, A. Corsini, M. Ruscica, R. Gualtierotti
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study
2024 M. Ruscica, C. Macchi, S. Gandini, D. Macis, A. Guerrieri-Gonzaga, V. Aristarco, D. Serrano, M. Lazzeroni, A.S. Rizzuto, A. Gaeta, A. Corsini, M. Gulisano, H. Johansson, B. Bonanni
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
2024 A. Gallo, W. Le Goff, R.D. Santos, I. Fichtner, S. Carugo, A. Corsini, C. Sirtori, M. Ruscica
Characterization of replicative and doxorubicin-induced senescence models in vascular smooth muscle cells
2023 C. Rossi, M. Venturin, C. Macchi, M. Ruscica, A. Corsini, C. Battaglia, S. Bellosta
Pollution from fine particulate matter and atherosclerosis: A narrative review
2023 C. Macchi, C.R. Sirtori, A. Corsini, P. Mannuccio Mannucci, M. Ruscica
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
2023 S. Carugo, C.R. Sirtori, G. Gelpi, A. Corsini, L. Tokgozoglu, M. Ruscica
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience
2023 P. Faggiano, M. Ruscica, S. Bettari, A. Cherubini, S. Carugo, A. Corsini, G. Barbati, A. Di Lenarda
Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms
2023 L. Lazzarato, L. Bianchi, A. Andolfo, A. Granata, M. Lombardi, M. Sinelli, B. Rolando, M. Carini, A. Corsini, R. Fruttero, L. Arnaboldi
Fixed Combination for the Treatment of Dyslipidaemia
2023 N. Ferri, M. Ruscica, R.D. Santos, A. Corsini
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
2023 E. Raschi, M. Casula, A.F.G. Cicero, A. Corsini, C. Borghi, A. Catapano
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
2023 M. Ruscica, C. Macchi, A. Giuliani, A.S. Rizzuto, D. Ramini, M. Sbriscia, S. Carugo, A.R. Bonfigli, A. Corsini, F. Olivieri, J. Sabbatinelli
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence
2023 C. Rossi, M. Venturin, J. Gubala, A. Frasca, A. Corsini, C. Battaglia, S. Bellosta